Turnstone Biologics
Total Raised
$172.11MInvestors Count
18Deal Terms
2Funding, Valuation & Revenue
5 Fundings
Turnstone Biologics has raised $172.11M over 5 rounds.
Turnstone Biologics's latest funding round was a IPO for $80M on July 21, 2023.
Turnstone Biologics's 2021 revenue was $101.29M. Turnstone Biologics's most recent revenue is from 2021.
Sign up for a free demo to see revenue data from 2023 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
7/21/2023 | IPO | $80M | 2 | |||
7/14/2021 | Series D | $101.29M (3.67x) FY 2021 | ||||
1/18/2019 | Series C | |||||
11/2/2016 | Series B | |||||
10/28/2015 | Series A |
Date | 7/21/2023 | 7/14/2021 | 1/18/2019 | 11/2/2016 | 10/28/2015 |
|---|---|---|---|---|---|
Round | IPO | Series D | Series C | Series B | Series A |
Amount | $80M | ||||
Investors | |||||
Valuation | |||||
Revenue | $101.29M (3.67x) FY 2021 | ||||
Sources | 2 |
Turnstone Biologics Deal Terms
2 Deal Terms
Turnstone Biologics's deal structure is available for 2 funding rounds, including their Series B from November 02, 2016.
Round | Series B | Series A |
|---|---|---|
Funding Date | ||
Pre-Money Valuation | ||
Post-Money Valuation | ||
Amount Raised | ||
Shares Authorized | ||
Issuance Price | ||
Dividend Rate | ||
Liquidation Preferences | ||
Liquidation Price | ||
Participation | ||
Conversion Price | ||
Anti Dilution | ||
General Voting | ||
Board Voting | ||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B | |||||||||||||||
Series A |
Turnstone Biologics Investors
18 Investors
Turnstone Biologics has 18 investors. XOMA invested in Turnstone Biologics's Acq - Pending funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
6/27/2025 | 6/27/2025 | 1 Acq - Pending | Corporation | California | ||
10/28/2015 | 7/14/2021 | 4 Series A, Series B (2016), Series C (2019), Series D (2021) | Venture Capital | California | ||
11/2/2016 | 7/14/2021 | 3 Series B, Series C (2019), Series D (2021) | Venture Capital | New York | ||
Venture Capital | Massachusetts | |||||
Venture Capital | Illinois |
First funding | 6/27/2025 | 10/28/2015 | 11/2/2016 | ||
|---|---|---|---|---|---|
Last Funding | 6/27/2025 | 7/14/2021 | 7/14/2021 | ||
Investor | |||||
Rounds | 1 Acq - Pending | 4 Series A, Series B (2016), Series C (2019), Series D (2021) | 3 Series B, Series C (2019), Series D (2021) | ||
Board Seats | |||||
Type | Corporation | Venture Capital | Venture Capital | Venture Capital | Venture Capital |
Location | California | California | New York | Massachusetts | Illinois |
Turnstone Biologics Acquisitions
1 Acquisition
Turnstone Biologics acquired 1 company. Their latest acquisition was Myst Therapeutics on January 20, 2021.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
1/20/2021 | Acquired | 5 |
Date | 1/20/2021 |
|---|---|
Investment Stage | |
Companies | |
Valuation | |
Total Funding | |
Note | Acquired |
Sources | 5 |
Loading...